It can cause or worsen halitosis by slowing digestion, which promotes bacterial growth in the mouth, and by reducing saliva production, which further contributes to this effect
Navigating these social changes is an important but often overlooked aspect of the GLP-1 transformation journey
Physiological Reviews , 91(4), 1409-1439
Further subgroup analysis revealed that, compared to diabetic populations, semaglutide had a more significant reduction in SBP ( 1.87, 95% CI 2.67 to 1.06, vs 5.02, 95% CI 6.10 to 3.94) and DBP ( 0.43, 95% CI 0.89 to 0.02, vs 1.96, 95% CI 3.12 to 0.80) in non-diabetic populations
FDA-approved semaglutide from Novo Nordisk undergoes rigorous manufacturing controls, batch testing, stability studies, and quality assurance processes mandated by the FDA